5. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC (1996) A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13: 1701–1707. 6. Hilger-Eversheim K, Moser M, Schorle H, Buettner R (2000) Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260: 1–12. 7. Oyama N, Takahashi H, Tojo M, Iwatsuki K, Iizuka H, et al. (2002) Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP- 2 in the expression of human keratinocyte genes. Arch Dermatol Res 294: 273–280. 8. Gille J, Reisinger K, Asbe-Vollkopf A, Hardt-Weinelt K, Kaufmann R (2000) Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor. J Invest Dermatol 115: 30–36. 9. Orso F, Penna E, Cimino D, Astanina E, Maione F, et al. (2008) AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 22: 2702–2714. 10. Jones PL, Wolffe AP (1999) Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol 9: 339–347. 11. Fujita N, Takebayashi S, Okumura K, Kudo S, Chiba T, et al. (1999) Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol 19: 6415–6426. 12. Singh H, Sekinger EA, Gross DS (2000) Chromatin and cancer: causes and consequences. J Cell Biochem Suppl Suppl 35: 61–68. 13. Uramoto H, Wetterskog D, Hackzell A, Matsumoto Y, Funa K (2004) p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor. J Cell Sci 117: 5323–5331. 14. Bennett KL, Romigh T, Arab K, Teresi RE, Tada Y, et al. (2009) Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma. Int J Cancer 124: 1285–1292. 15. Liu H, Tan BC, Tseng KH, Chuang CP, Yeh CW, et al. (2007) Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation. EMBO Rep 8: 394–400. 16. Zhang G, Veldhuis JD (2004) Requirement for proximal putative Sp1 and AP-2 cis-deoxyribonucleic acid elements in mediating basal and luteinizing hormone- and insulin-dependent in vitro transcriptional activation of the CYP17 gene in porcine theca cells. Endocrinology 145: 2760–2766. 17. Taylor KH, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, et al. (2007) Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res 67: 2617–2625. 18. Suyama E, Minoshima H, Kawasaki H, Taira K (2002) Identification of AP-2- regulated genes by macroarray profiling of gene expression in human A375P melanoma. Nucleic Acids Res Suppl: 247–248. 19. Choi HJ, Chung TW, Kim SJ, Cho SY, Lee YS, et al. (2008) The AP-2alpha transcription factor is required for the ganglioside GM3-stimulated transcrip- tional regulation of a PTEN gene. Glycobiology 18: 395–407. 20. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG (1998) MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17: 2413–2417. AP-2a Targets Methylation 21. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, et al. (1999) hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59: 159–164. 22. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, et al. (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58: 1713–1718. 23. Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, et al. (2007) Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res 13: 2541–2548. 24. McCool KW, Xu X, Singer DB, Murdoch FE, Fritsch MK (2007) The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. J Biol Chem 282: 6696–6706. 25. Provenzano MJ, Yu L, Hitchler MJ, Fitzgerald MP, Robinson RA, et al. (2007) AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma. Exp Mol Pathol 83: 277–282. 26. Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, et al. (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling. Mol Cell Biol 29: 172–186. 27. Yu Y, Wang Y, Li M, Kannan P (2002) Tumorigenic effect of transcription factor hAP-2alpha and the intricate link between hAP-2alpha activation and squelching. Mol Carcinog 34: 172–179. 28. Schulte JH, Kirfel J, Lim S, Schramm A, Friedrichs N, et al. (2008) Transcription factor AP2alpha (TFAP2a) regulates differentiation and prolifer- ation of neuroblastoma cells. Cancer Lett 271: 56–63. 29. Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, et al. (2007) Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther 6: 1650–1660. 30. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257. 31. Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, et al. (2006) Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19: 59–68. 32. Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N (2006) Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol 17: 995–999. 33. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, et al. (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 4749–4756. 34. Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, et al. (2007) Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res 67: 4657–4664. 35. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, et al. (2006) Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst 98: 396–406. PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e6931